Cargando…
Lacticaseibacillus rhamnosus FM9 and Limosilactobacillus fermentum Y57 Are as Effective as Statins at Improving Blood Lipid Profile in High Cholesterol, High-Fat Diet Model in Male Wistar Rats
Elevated serum cholesterol is a major risk factor for coronary heart diseases. Some Lactobacillus strains with cholesterol-lowering potential have been isolated from artisanal food products. The purpose of this study was to isolate probiotic Lactobacillus strains from traditional yoghurt (dahi) and...
Autores principales: | Zafar, Hamza, Ain, Noor ul, Alshammari, Abdulrahman, Alghamdi, Saeed, Raja, Hafsa, Ali, Amjad, Siddique, Abubakar, Tahir, Syeda Duaa, Akbar, Samina, Arif, Maryum, Alharbi, Metab, Rahman, Abdur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027066/ https://www.ncbi.nlm.nih.gov/pubmed/35458216 http://dx.doi.org/10.3390/nu14081654 |
Ejemplares similares
-
Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats
por: Li, Yanjun, et al.
Publicado: (2022) -
Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2?
por: Valdebenito-Navarrete, Héctor, et al.
Publicado: (2023) -
Feeding Limosilactobacillus fermentum K9-2 and Lacticaseibacillus casei K9-1, or Limosilactobacillus reuteri TMW1.656 Reduces Pathogen Load in Weanling Pigs
por: Wang, Weilan, et al.
Publicado: (2020) -
Probiotic Potential Lacticaseibacillus casei and Limosilactobacillus fermentum Strains Isolated from Dosa Batter Inhibit α-Glucosidase and α-Amylase Enzymes
por: Kumari V. B., Chandana, et al.
Publicado: (2022) -
Metabolites Potentially Determine the High Antioxidant Properties of Limosilactobacillus fermentum U-21
por: Grishina, Yelena V., et al.
Publicado: (2023)